Stocks To Buy

NVIDIA just reported a quarter that would make any CEO weep with joy — $68.13 billion in revenue, a 73% year-over-year surge — and the stock barely moved in after-hours trading. Welcome to the new normal in AI investing, where "incredible" is already priced in. The chipmaker's fiscal Q4 results crushed expectations across the board. Revenue obliterated the $65.7 billion consensus. The Blackwell GPU platform is shipping at scale, hyperscalers are spending north of $500 billion on AI infrastructure, and Jensen ...
Read More About This

So, AI is apparently eating the world again. But this time, instead of everyone getting hyped about robot butlers and self-driving cars, Wall Street is having a full-blown existential crisis. Software stocks are getting absolutely demolished, and suddenly everyone's wondering if their favorite tech darlings are about to become as relevant as a Blockbuster store. Enter Morgan Stanley with their "Most Defensible Stocks" list – basically their version of a financial bunker for when the AI apocalypse comes knocking. And honestly? ...
Read More About This

So Warner Bros Discovery (WBD) just had the kind of day that makes you wish you'd bought the stock yesterday instead of that overpriced coffee. The stock absolutely rocketed 28% on Thursday after the Wall Street Journal dropped some juicy gossip: Paramount Skydance might want to buy the whole dang company. Now, before you start picturing David Ellison (Paramount's CEO) sliding into Warner Bros' DMs, let's break down what's actually happening here. This isn't just some random corporate crush – there's ...
Read More About This

Remember when your uncle at Thanksgiving dinner claimed he "saw the election coming" because of some random poll? Well, turns out there's actually a way to see the future – and it's not reading tea leaves or following Jim Cramer's latest hot take. Enter prediction markets: the lovechild of Vegas and Wall Street that's quietly eating everyone's lunch. Here's the deal: While talking heads on CNBC are still debating whether something might happen, prediction markets like Kalshi and Polymarket are already pricing ...
Read More About This

While most restaurant stocks are grinding through a cautious consumer environment, CAVA Group just dropped a quarter that makes the rest of the industry look like it's standing still. The Mediterranean fast-casual chain reported fiscal year 2025 revenue of $1.17 billion — crossing the billion-dollar mark for the first time in company history — representing 22.5% growth over the prior year. Same-restaurant sales grew 4% for the full year. The company opened 72 net new locations, bringing its total restaurant count ...
Read More About This

When Tesla announced it would shut down production of the Model S and Model X — two of the cars that put the company on the map — to convert that factory space into a robot manufacturing facility, it wasn't just a product decision. It was a declaration. "It is time to bring the S and X programs to an end and shift to an autonomous future," CEO Elon Musk told analysts during the Q4 earnings call. That sentence is worth ...
Read More About This

Something is breaking in the "buy America" trade — and the numbers are hard to ignore. U.S.-domiciled investors have yanked roughly $75 billion out of American equity products over the past six months, with $52 billion of that flowing out since January 1st alone. That's the fastest eight-week exodus since at least 2010, according to LSEG/Lipper data. For a market that spent the last 15 years as the undisputed gravitational center of global capital, this is a seismic shift. So where's the ...
Read More About This

Remember when Coke and Pepsi were duking it out for soda supremacy? Well, there's a new corporate cage match in town, except instead of selling sugar water, these companies are helping people lose weight. Plot twist of the century. Meet the heavyweight champions: Eli Lilly (LLY) and Novo Nordisk (NVO). These pharma giants are throwing haymakers over who gets to dominate the GLP-1 weight-loss market, and yesterday's scorecard was... let's just say someone got their lunch money taken. The Setup These drugs started ...
Read More About This